Concepedia

Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy

Mgs. Irsan Saleh, Ziske Maritska, Nita Parisa, Rachmat Hidayat

Open Access Macedonian Journal of Medical Sciences · 2019 · 21 citations · 10 references

DOIFull text

Open access

Abstract

Inhibition of receptor for advanced glycation end-products (RAGE) was effective in suppressing the development and progression of diabetic retinopathy.

References

10

Pegaptanib for Neovascular Age-Related Macular Degeneration

Evangelos S. Gragoudas, Anthony P. Adamis, Emmett T. Cunningham et al. · New England Journal of Medicine · 2004 · 2.3K citations · Full text

A Common Polymorphism in the 5′-Untranslated Region of the VEGF Gene Is Associated With Diabetic Retinopathy in Type 2 Diabetes

Takuya Awata, Kiyoaki Inoue, Susumu Kurihara et al. · Diabetes · 2002 · 560 citations · Full text

VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Evangelos S. Gragoudas, A.P. Adamis, Emmett T. Cunningham et al. · 2004 · 473 citations

, , +6

Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy.

Suganthalakshmi Balasubbu, Anand Rajendran, Kim Ramasamy et al. · PubMed · 2006 · 134 citations

The DiabCare Asia 2008 study – Outcomes on control and complications of type 2 diabetic patients in Indonesia

Pradana Soewondo, Sidartawan Soegondo, Ketut Suastika et al. · Medical Journal of Indonesia · 2010 · 98 citations · Full text

, , +17